C
Cibus
Cibus has developed plant and microbial platforms
About Cibus
Cibus is a pioneering company in the agricultural biotechnology sector, specializing in the development of non-GMO (non-genetically modified organism) plant traits. The company leverages its proprietary precision gene editing technology, RTDS (Rapid Trait Development System), to introduce desirable characteristics into crops much faster than traditional breeding methods. These traits include herbicide tolerance, disease resistance, and improved nutritional profiles, aimed at meeting the demands of farmers and enhancing human health. Cibus operates in the global agricultural market, serving farmers, seed developers, and the broader agricultural community. The company's business model involves both the direct deployment of these traits into its own products and collaborations with seed developers to integrate these traits into a variety of crops. Revenue is generated through the commercialization of these enhanced crops and partnerships with other agricultural entities. Currently, Cibus is nearing the commercial rollout of its weed tolerance traits in flax and rice and is developing traits for wheat, soybean, and corn. The company's mission is to innovate for a sustainable future by improving crop productivity, enhancing food health and nutrition, and protecting the planet by growing healthier food with fewer resources.
Source: Dealroom company dataAt a glance
- Status
- Listed
- Founded
- 2001
- Headquarters
- San Diego, United States
- Listing
- IPO 2023
- Employees
- 320
- Open positions
- 2
- Dealroom signal
- 67.6/100
- Industry
- Food
- Sub-industry
- AgriTech
- Sector
- Food, Biotechnology, DNA, Crop Protection, Genetics and genomics, Synthetic Biology, Spinout, Genome Engineering, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
- Investment activity
- 2 companies, latest Jan 2023
- Capital deployed
- $25M
- Preferred round
- SERIES C
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITYOther financing | Mar 2026 | $15M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Jun 2025 | $28M | — | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $7.8M | +113.8% | −$61M | -780.2% |
| 2025 | $3.6M | -14.6% | −$61M | -1668.1% |
| 2024 | $4.3M | +134.6% | −$60M | -1412.6% |
| 2023 | $1.8M | +1057.3% | −$65M | -3557.5% |
| 2022 | $157K | -99.4% | −$22M | -14248.4% |
| 2021 | $26M | +9% | −$29M | -109.8% |
| 2020 | $24M | — | −$41M | -170.2% |
Growth signals
Latest recorded traffic for Cibus is 3.9K monthly website visits, down 43.5% over the last three months. Cibus's team declined 0.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
CalyxtRoseville, United StatesAgbiotech company focused on developing crops with healthier characteristics
$122Mvaluation
Vive Crop ProtectionMississauga, CanadaVive creates new possibilities in crop protection
$125Mvaluation
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Fidelity Investments
Alexandria Venture Investments
Cormorant Asset Management
Other known investors1 additional known investor
Boyce Thompson Institute
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Cibus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cibus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.